Interagency Coordination in Drug Research and Regulation: Supplementary exhibits and index to parts 1 and 2

Interagency Coordination in Drug Research and Regulation: Supplementary exhibits and index to parts 1 and 2
Author: United States. Congress. Senate. Committee on Government Operations
Publisher:
Total Pages: 484
Release: 1963
Genre: Drugs
ISBN:

Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use, drugs for mental illness, neonatal pharmacology, etc.

Interagency Coordination in Drug Research and Regulation

Interagency Coordination in Drug Research and Regulation
Author: United States. Congress. Senate. Committee on Government Operations. Subcommittee on Reorganization and International Organizations
Publisher:
Total Pages: 1320
Release: 1963
Genre: Drugs
ISBN:

Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use.

Interagency Coordination in Drug Research and Regulation: Testimony and exhibits (including subsequent correspondence) on specialized drugs and drug problems: 1) drugs for mental illness; 2) antibiotics; 3) drug testing; 4) neonatal pharmacology; and 5) communication on drug emergencies

Interagency Coordination in Drug Research and Regulation: Testimony and exhibits (including subsequent correspondence) on specialized drugs and drug problems: 1) drugs for mental illness; 2) antibiotics; 3) drug testing; 4) neonatal pharmacology; and 5) communication on drug emergencies
Author: United States. Congress. Senate. Committee on Government Operations
Publisher:
Total Pages: 924
Release: 1964
Genre: Drugs
ISBN:

Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use, drugs for mental illness, neonatal pharmacology, etc.